The abstract is read at the publisher; the summary is JClub's.
In a single-center cohort of 107 adults with Candida auris candidemia, 28-day mortality was 41.1% (44/107) and was independently linked to higher Charlson Comorbidity Index and SOFA scores.
- Why it matters: Mortality from Candida auris bloodstream infection remains high and treatment options are limited, but clinicians need local predictors and susceptibility patterns to guide management and infection control.
- What they did: Adults treated between June 2022 and December 2025 were retrospectively reviewed (108 enrolled; mortality available for 107), with antifungal susceptibility summarized by resistance rates and multivariable models testing predictors of 28-day death.
- The result: Charlson Comorbidity Index (aOR 1.22; 95% CI 1.02–1.44) and SOFA score (aOR 1.16; 95% CI 1.05–1.27) predicted 28-day mortality, while resistance was common to fluconazole (95.1%) and multidrug resistance occurred in 28.6%.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.